-
Johnson & Johnson could learn a thing or two from Smith & Nephew
- Jun 6, 2012
-
FDA advisory panel under scrutiny for voting against Yaz® recall
- Mar 21, 2012
-
Canada adds heart warnings to Lexapro labels
- May 7, 2012
-
Injection restores sight
- Jul 26, 2012
-
Pradaxa® and Xarelto® linked to internal bleeding
- Feb 9, 2012
-
New study reveals sleeping pill risks
- Mar 27, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
blood clots Urban Products Johnson & Johnson Lexapro pulmonary embolism Xarelto Roche dangerous products EMA heart attack pulomonary embolism blood thinner Technology Design yo Eliquis fentanyl patch Nexavar Nexavar pulmonary embolism diet drug kidney problems medical malpractice Tempah Johnson & Johnson lawsuits ADHD Belviq coumadin Adderall